Bryan D. Marks

16 papers and 430 indexed citations i.

About

Bryan D. Marks is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Bryan D. Marks has authored 16 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Bryan D. Marks’s work include Pharmacogenetics and Drug Metabolism (6 papers), Computational Drug Discovery Methods (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Bryan D. Marks is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Computational Drug Discovery Methods (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Bryan D. Marks collaborates with scholars based in United States. Bryan D. Marks's co-authors include Olga V. Trubetskoy, William J. Frazee, Steven M. Riddle, Kurt W. Vogel, Connie S. Lebakken, Mary Szatkowski Ozers, Upinder Singh, Mohammed Saleh Shekhani, Judy L. Raucy and Mei‐Fei Yueh and has published in prestigious journals such as Blood, Biochemistry and Cancer Research.

In The Last Decade

Co-authorship network of co-authors of Bryan D. Marks i

Fields of papers citing papers by Bryan D. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan D. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan D. Marks. The network helps show where Bryan D. Marks may publish in the future.

Countries citing papers authored by Bryan D. Marks

Since Specialization
Citations

This map shows the geographic impact of Bryan D. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan D. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan D. Marks more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025